Tympa Health

Founded 2017
Employees 50+
Primary contact
33 Cavendish Square
W1G 0PW London
United Kingdom
Sections
Tympa has developed a solution allowing fully digitized comprehensive ear and hearing health assessments to be performed across both traditional clinical and community-based settings. By creating a solution that brings ENT expertise to community settings, Tympa increases cost-effective access to care and supports earlier disease detection. TympaHealth is CE-marked, FDA-registered, and the only solution of its kind dedicated to the democratization of ear and hearing healthcare. Also, the Tympa Platform allows a much broader range of professionals to perform digital otoscopy, microsuction wax removal, and hearing assessments.
Select partners: Boots Hearingcare, Hidden Hearing, Bupa, Day Lewis Pharmacy, Sonova, NHS University College London Hospitals, Amplify.
Founded 2017
Employees 50+
Primary contact
33 Cavendish Square
W1G 0PW London
United Kingdom
Sections

Funding πŸ’°

Total $31M
Last round πŸ”— $23M
Series A
April 27, 2023.
Select investors Octopus Ventures, Dara Capital, Rezayat Investments, Innovate UK

Key people πŸ§‘β€πŸ€β€πŸ§‘

Highlights ⭐

  • Big need: The World Health Organization estimates that unaddressed hearing loss costs the global economy $980bn annually due to health sector costs, costs of educational support, loss of productivity, and societal costs. In the UK, over 25% of adults who report hearing problems to their primary care physician are not referred to the NHS hearing services or they drop out during the treatment and diagnosis process due to disjointed health pathways. The US Healthcare system faces similar problems with 14% of Americans suffering with some form of hearing loss. Hearing loss is also recognised as the single biggest modifiable risk factor for prevention of dementia and linked to increased falls and social isolation. πŸ”—
  • It's both effective & efficient: Tympa's comprehensive examination is digitally captured in a single hearing health record, which can be shared between patients, providers, and specialists seamlessly. In that sense, Tympa Health not only makes ear and hearing health services more accessible to patients, it also reduces the time and cost associated with unnecessary primary care and hospital visits.
  • World-leading researchers: Tympa has a team of world-leading researchers from the fields of ENT, Audiology, Physics, and Machine Learning dedicated to helping the world hear better. Beyond expanding its services within communities, the company is continually making scientific advances through clinically validated and peer-reviewed research. πŸ”—
  • Tympa Academy: The company's Tympa Academy offering enables clinicians from all backgrounds to deliver ear and hearing healthcare services. Created by a team of professional audiologists, the program offers a blend of webinars, online education, and face-to-face coaching and is officially accredited by The British Society of Audiology (BSA) and The British Society of Hearing Aid Audiologists (BSHAA).
  • Eyes on Europe and the US: On the heels of its Series A funding in April 2023, the company said it will use the funds to grow its team and services in the UK, across Europe and entering into the US. As part of that plan, the company hired industry veteran David Horowitz, formerly of Oticon, as its new US Vice President of Sales.

Video ▢️

Awards & Recognitions πŸ†

  • 2022 Prix Galien Award Nominee πŸ”—
  • 2021 iF Design Award 2021 πŸ”—
  • 2020 GOOD DESIGN award by The Chicago Athenaeum πŸ”—
  • 2020 Gold UX Design Award (UXDA) by the International Design Centre Berlin (IDZ) πŸ”—
  • 2020 The Royal Society of Medicine Mr N Shah ENT Innovation Award πŸ”—
  • 2020 Best Hearing Health Tech Company & Most Advanced Audiology Assessments System πŸ”—

Quotes πŸ’¬

The TympaHealth proposition is a fantastic exemplar for the quality of high growth healthtech and life science businesses we have in the UK. Using a high-quality product and a proposition geared around the consumer, they are reducing the burden of ear and hearing care in an overstretched NHS, while vastly improving patient experience and outcomes. They are building exactly the kind of game changing business we look to support, and they are in a market with huge potential. We couldn't be happier to be backing them as they seize that potential and democratise ear and hearing healthcare access globally.
Joe Stringer, Partner at Octopus Ventures πŸ”—
TympaHealth can deliver ear and hearing health services safely into the community and away from the hospital, expanding critical access for patients. It is doing so effectively in the UK and it is great to see an NHS innovation taking the next step of their journey.
Chairman of the National Health Service (NHS), Lord David Prior πŸ”—
Tympa is the perfect combination of intuitive technology and improved access to care that is driving our next generation patient-centric approach to earlier disease detection and modification.
Anil Sethi, former Apple Health Executive and Founder of Gliipmse and Ciitizen πŸ”—
Last update: May 2, 2023